Literature DB >> 20726703

A physiological systems model for iodine for use in radiation protection.

R W Leggett1.   

Abstract

This paper summarizes the biokinetic database for iodine in the human body and proposes a biokinetic model for systemic iodine for use in dose assessments for internally deposited radioiodine. The model consolidates and extends existing physiological systems models describing three subsystems of the iodine cycle in the body: circulating inorganic iodide, thyroidal iodine (trapping and organic binding of iodide and synthesis, storage and secretion of thyroid hormones), and extrathyroidal organic iodine. Thyroidal uptake of inorganic iodide is described as a function of stable iodine intake (Y, µg day(-1)) and thyroidal secretion of hormonal iodine (S, µg day(-1)). Baseline parameter values are developed for reference adults with typical iodine intake. Compared with the current systemic biokinetic model of the International Commission on Radiological Protection (ICRP) for occupational intake of radioiodine, the proposed model predicts higher absorbed doses to the thyroid per unit uptake to blood for very short-lived iodine isotopes, similar absorbed doses to thyroid for iodine isotopes with half-life of at least a few hours, and substantially higher estimates of absorbed dose to stomach wall, salivary gland and kidneys for most iodine isotopes. Absorbed dose estimates for intravenous administration of radioiodine-labeled thyroid hormones based on the proposed model differ substantially in some cases from current ICRP values.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20726703     DOI: 10.1667/RR2243.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  14 in total

1.  Investigation of factors influencing radioiodine (131I) biokinetics in patients with benign thyroid disease using nonlinear mixed effects approach.

Authors:  Valentina Topić Vučenović; Zvezdana Rajkovača; Dijana Jelić; Dragi Stanimirović; Goran Vuleta; Branislava Miljković; Katarina Vučićević
Journal:  Eur J Clin Pharmacol       Date:  2018-05-13       Impact factor: 2.953

2.  Uncertainty quantification of bioassay functions for the internal dosimetry of radioiodine.

Authors:  Tae-Eun Kwon; Yoonsun Chung; Jaeryong Yoo; Wi-Ho Ha; Minsu Cho
Journal:  J Radiat Res       Date:  2020-11-16       Impact factor: 2.724

3.  Excretion of radionuclides in human breast milk after nuclear medicine examinations. Biokinetic and dosimetric data and recommendations on breastfeeding interruption.

Authors:  Sigrid Leide-Svegborn; Lars Ahlgren; Lennart Johansson; Sören Mattsson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-01-06       Impact factor: 9.236

4.  Measurement of 131I activity in air indoor Polish nuclear medical hospital as a tool for an internal dose assessment.

Authors:  K Brudecki; A Szczodry; T Mróz; A Kowalska; J W Mietelski
Journal:  Radiat Environ Biophys       Date:  2017-12-14       Impact factor: 1.925

5.  Repeated KI Prophylaxis in Case of Prolonged Exposure to Iodine Radioisotopes: Pharmacokinetic Studies in Adult Rats.

Authors:  Guillaume Phan; Rym Chioukh; David Suhard; Alexandre Legrand; Charlotte Moulin; Thibaud Sontag; François Rebière; Céline Bouvier-Capely; Michelle Agarande; Valérie Renaud-Salis; Jean-René Jourdain
Journal:  Pharm Res       Date:  2018-10-08       Impact factor: 4.200

6.  Optimal KI Prophylactic Dose Determination for Thyroid Radiation Protection After a Single Administration in Adult Rats.

Authors:  Guillaume Phan; François Rebière; David Suhard; Alexandre Legrand; Floriane Carpentier; Thibaud Sontag; Maâmar Souidi; Jean-René Jourdain; Michelle Agarande; Valérie Renaud-Salis
Journal:  Dose Response       Date:  2017-12-13       Impact factor: 2.658

7.  IDAC-Dose 2.1, an internal dosimetry program for diagnostic nuclear medicine based on the ICRP adult reference voxel phantoms.

Authors:  Martin Andersson; Lennart Johansson; Keith Eckerman; Sören Mattsson
Journal:  EJNMMI Res       Date:  2017-11-03       Impact factor: 3.138

8.  Measurement of 131I activity in thyroid of nuclear medical staff and internal dose assessment in a Polish nuclear medical hospital.

Authors:  K Brudecki; A Kowalska; P Zagrodzki; A Szczodry; T Mroz; P Janowski; J W Mietelski
Journal:  Radiat Environ Biophys       Date:  2016-12-31       Impact factor: 1.925

9.  131I age-dependent inhalation dose in Southern Poland from Fukushima accident.

Authors:  K Brudecki; K Szufa; J W Mietelski
Journal:  Radiat Environ Biophys       Date:  2016-12-23       Impact factor: 1.925

10.  Microdosimetric analysis confirms similar biological effectiveness of external exposure to gamma-rays and internal exposure to 137Cs, 134Cs, and 131I.

Authors:  Tatsuhiko Sato; Kentaro Manabe; Nobuyuki Hamada
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.